Global Immortalized Human Cells Market Growth 2024-2030

The global Immortalized Human Cells market size is predicted to grow from US$ 1619 million in 2024 to US$ 2630 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.

Immortalized human cells refer to specially treated cells that can proliferate indefinitely in the laboratory without entering the aging stage. Normally, normal human cells enter a state of aging after a certain number of divisions and eventually stop dividing. However, by introducing specific genes (such as the telomerase gene) or treating them with certain chemicals, these cells are "immortalized" and can survive and reproduce for a long time in vitro culture.

United States market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Immortalized Human Cells players cover Lonza, Thermo Fisher Scientific, JSR, Valneva, Sartorius, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Immortalized Human Cells Industry Forecast” looks at past sales and reviews total world Immortalized Human Cells sales in 2023, providing a comprehensive analysis by region and market sector of projected Immortalized Human Cells sales for 2024 through 2030. With Immortalized Human Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immortalized Human Cells industry.

This Insight Report provides a comprehensive analysis of the global Immortalized Human Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immortalized Human Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immortalized Human Cells market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immortalized Human Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immortalized Human Cells.

This report presents a comprehensive overview, market shares, and growth opportunities of Immortalized Human Cells market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Ready-to-use
Customized

Segmentation by Application:
Medical Research
Vaccine Development
Gene Therapy
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lonza
Thermo Fisher Scientific
JSR
Valneva
Sartorius
Merck
Charles River Laboratories
Creative Bioarray
LABTOO
Cytion
EditCo
Howard Hughes Medical Institute
AcceGen
BioIVT LLC
BioCat GmbH
Cytosurge

Key Questions Addressed in this Report

What is the 10-year outlook for the global Immortalized Human Cells market?

What factors are driving Immortalized Human Cells market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Immortalized Human Cells market opportunities vary by end market size?

How does Immortalized Human Cells break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.